DOCSLIB.ORG

Bleomycin-Induced Lung Injury Receptor in Acute and Chronic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Distinct Roles for the A2B Adenosine Receptor in Acute and Chronic Stages of Bleomycin-Induced Lung Injury This information is current as Yang Zhou, Daniel J. Schneider, Eva Morschl, Ling Song, of September 25, 2021. Mesias Pedroza, Harry Karmouty-Quintana, Thuy Le, Chun-Xiao Sun and Michael R. Blackburn J Immunol 2011; 186:1097-1106; Prepublished online 13 December 2010; doi: 10.4049/jimmunol.1002907 Downloaded from http://www.jimmunol.org/content/186/2/1097 References This article cites 49 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/186/2/1097.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 25, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Distinct Roles for the A2B Adenosine Receptor in Acute and Chronic Stages of Bleomycin-Induced Lung Injury Yang Zhou,*,† Daniel J. Schneider,*,† Eva Morschl,* Ling Song,* Mesias Pedroza,*,† Harry Karmouty-Quintana,* Thuy Le,*,† Chun-Xiao Sun,* and Michael R. Blackburn*,† Adenosine is an extracellular signaling molecule that is generated in response to cell injury where it orchestrates tissue protection and repair. Whereas adenosine is best known for promoting anti-inflammatory activities during acute injury responses, prolonged elevations can enhance destructive tissue remodeling processes associated with chronic disease states. The generation of adenosine and the subsequent activation of the adenosine 2B receptor (A2BR) is an important processes in the regulation of both acute and chronic lung disease. The goal of this study was to examine the contribution of the A2BR in models of bleomycin-induced lung injury that exhibit varying degrees of acute and chronic injury. Intratracheal bleomycin exposure results in substantial acute lung injury followed by progressive fibrosis. In this model, genetic removal of the A2BR resulted in enhanced loss of barrier function Downloaded from and increased pulmonary inflammation, with few differences in indexes of pulmonary fibrosis. These results support an anti- inflammatory role for this receptor in this model of acute lung injury. In contrast, systemic exposure of mice to bleomycin resulted in modest acute lung injury together with progressive pulmonary fibrosis. In this model, the effects of A2BR removal on acute lung injury were negligible; however, there were substantial reductions in pulmonary fibrosis, supporting a profibrotic role for this receptor. A2BR-dependent regulation of IL-6 production was identified as a potential mechanism involved in the diminished http://www.jimmunol.org/ pulmonary fibrosis seen in A2BR knockout mice exposed to i.p. bleomycin. These studies highlight the distinct roles of A2BR signaling during acute and chronic stages of lung injury. The Journal of Immunology, 2011, 186: 1097–1106. cute lung injuries and chronic lung diseases are collec- Adenosine exerts its activities by engaging cell-surface adeno- tively the third leading cause of death in the United States sine receptors. There are four adenosine receptors (A1R, A2AR, (1). Treatment options for these pulmonary disorders are A A2BR, A3R) that are widely distributed on inflammatory and limited due in part to an incomplete understanding of the cellular stromal cells (13, 14). Recent studies have identified the adenosine and molecular pathways involved in the lung’s ability to respond 2B receptor (A2BR) as an important target in the regulation of both to various forms of injury. Adenosine is an extracellular signaling acute and chronic lung disease; however, with opposing activities by guest on September 25, 2021 molecule that is generated in response to cell injury where it in these disorders. Agonists for the A2BR are being considered for orchestrates tissue protection and repair (2). Whereas adenosine the treatment of acute lung injury based on findings demonstrating is best known for promoting anti-inflammatory activities during that activation of this receptor can enhance pulmonary barrier acute injury responses (3, 4), prolonged elevations in adenosine function and dampen inflammation in models of acute lung injury can enhance destructive tissue remodeling processes associated (7, 8). In contrast, A R antagonists are being considered for the with chronic disease states (5, 6). Consistent with this paradigm, 2B treatment of chronic lung diseases based on results demonstrating adenosine serves as an anti-inflammatory molecule in models of that blockade of this receptor can diminish airspace destruction acute lung injury (7–10), whereas elevations in adenosine con- tribute to disease progression in models of chronic lung disease and fibrosis (11). These findings emphasize that understanding the (11, 12). Thus, adenosine signaling may play an important role in contribution of the A2BR to the regulation of processes associated regulating how the lung responds to injury, and targeting this with acute and chronic lung injury will be essential for guiding the pathway may provide avenues for enhancing the resolution of use of A2BR agonists and antagonists for the treatment of these acute lung injury or halting the progression of chronic lung dis- disorders. ease. Recent studies from our laboratory suggest that A2BR signaling represents an important pathway for balancing the resolution of acute lung injury versus the progression to chronic disease *Department of Biochemistry and Molecular Biology, University of Texas Medical School at Houston, Houston, TX 77030; and †University of Texas Graduate School of (6). Mice deficient in the purine catabolic enzyme adenosine Biomedical Sciences at Houston, Houston, TX 77030 deaminase (ADA) develop features of chronic lung disease in Received for publication August 31, 2010. Accepted for publication November 17, association with prolonged adenosine elevations (15). The pro- 2010. minent aspects of pulmonary disease seen in this model include This work was supported in part by National Institutes of Health Grant HL70952 (to macrophage and neutrophil rich inflammation, alveolar airspace M.R.B.). destruction, and fibrosis (15, 16). Genetic removal the A2BR Address correspondence and reprint request to Michael R. Blackburn, Department of from ADA-deficient mice resulted in enhanced acute lung injury Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, 6431 Fannin, Houston, TX 77030. E-mail address: michael.r.blackburn@ characterized by the loss of vascular–alveolar barrier function uth.tmc.edu and enhanced neutrophil accumulation (17). However, treatment Abbreviations used in this article: A2BR, adenosine 2B receptor; ADA, adenosine of these mice with a selective A2BR antagonist during chronic deaminase; BAL, bronchoalveolar lavage; IPF, idiopathic pulmonary fibrosis; i.t., stages of disease resulted in diminished pulmonary inflam- intratracheal; a-sma, a smooth muscle actin. mation, airspace destruction, and fibrosis (11). These findings Copyright Ó 2011 by The American Association of Immunologists, Inc. 0022-1767/11/$16.00 suggestthattheA2BR plays a protective role during acute stages www.jimmunol.org/cgi/doi/10.4049/jimmunol.1002907 1098 THE A2B ADENOSINE RECEPTOR IN LUNG DISEASE of lung injury, whereas detrimental effects of this signaling Intratracheal bleomycin treatment pathway are manifested at stages where tissue fibrosis is pro- Avertin (250 mg/kg, i.p.) was used to anesthetize 10-wk-old female C57BL/6 +/+ 2/2 minent. A2BR or A2BR mice, and saline alone or 2.5 U/kg bleomycin (Teva These findings support the hypothesis that the A2BR is anti- Parenteral Medicines, Irvine, CA) diluted in 50 ml sterile saline was in- inflammatory during acute lung injury and profibrotic during stilled intratracheally (19). Endpoints were examined at 7 and 21 d after chronic disease stages. The goal of the current study was to ex- exposure. amine this hypothesis further by exploring the consequences of Intraperitoneal bleomycin treatment genetic removal of this receptor in models of bleomycin-induced +/+ 2/2 Six-week-old male A2BR or A2BR mice were treated intraper- lung injury. Exposing mice to this toxicant by direct intratracheal itoneally with 0.035 U/g bleomycin (Teva Parenteral Medicines) diluted (i.t.) administration or systemic exposure resulted in pulmonary in 150 ml sterile PBS or PBS alone (20). Mice were treated twice weekly fibrosis that was preceded by varying degrees of acute lung injury. for 4 wk and were sacrificed on day 10 and 33. Mice exposed to i.t. bleomycin developed substantial acute lung Bronchoalveolar lavage and histology injury followed by fibrosis. In this model, genetic removal of the A R resulted in enhanced acute lung injury, with only modest Avertin was used to anesthetize mice, and airways were lavaged three times 2B with 0.4 ml PBS, and 1 ml bronchoalveolar lavage (BAL) fluid was re- decreases
Recommended publications
  • REDUCTION of PURINE CONTENT in COMMONLY CONSUMED MEAT PRODUCTS THROUGH RINSING and COOKING by Anna Ellington (Under the Directio

    REDUCTION of PURINE CONTENT in COMMONLY CONSUMED MEAT PRODUCTS THROUGH RINSING and COOKING by Anna Ellington (Under the Directio

    REDUCTION OF PURINE CONTENT IN COMMONLY CONSUMED MEAT PRODUCTS THROUGH RINSING AND COOKING by Anna Ellington (Under the direction of Yen-Con Hung) Abstract The commonly consumed meat products ground beef, ground turkey, and bacon were analyzed for purine content before and after a rinsing treatment. The rinsing treatment involved rinsing the meat samples using a wrist shaker in 5:1 ratio water: sample for 2 or 5 minutes then draining or centrifuging to remove water. The total purine content of 25% fat ground beef significantly decreased (p<0.05) from 8.58 mg/g protein to a range of 5.17-7.26 mg/g protein after rinsing treatments. After rinsing and cooking an even greater decrease was seen ranging from 4.59-6.32 mg/g protein. The total purine content of 7% fat ground beef significantly decreased from 7.80 mg/g protein to a range of 5.07-5.59 mg/g protein after rinsing treatments. A greater reduction was seen after rinsing and cooking in the range of 4.38-5.52 mg/g protein. Ground turkey samples showed no significant changes after rinsing, but significant decreases were seen after rinsing and cooking. Bacon samples showed significant decreases from 6.06 mg/g protein to 4.72 and 4.49 after 2 and 5 minute rinsing and to 4.53 and 4.68 mg/g protein after 2 and 5 minute rinsing and cooking. Overall, this study showed that rinsing foods in water effectively reduces total purine content and subsequent cooking after rinsing results in an even greater reduction of total purine content.
  • Chapter 23 Nucleic Acids

    Chapter 23 Nucleic Acids

    7-9/99 Neuman Chapter 23 Chapter 23 Nucleic Acids from Organic Chemistry by Robert C. Neuman, Jr. Professor of Chemistry, emeritus University of California, Riverside [email protected] <http://web.chem.ucsb.edu/~neuman/orgchembyneuman/> Chapter Outline of the Book ************************************************************************************** I. Foundations 1. Organic Molecules and Chemical Bonding 2. Alkanes and Cycloalkanes 3. Haloalkanes, Alcohols, Ethers, and Amines 4. Stereochemistry 5. Organic Spectrometry II. Reactions, Mechanisms, Multiple Bonds 6. Organic Reactions *(Not yet Posted) 7. Reactions of Haloalkanes, Alcohols, and Amines. Nucleophilic Substitution 8. Alkenes and Alkynes 9. Formation of Alkenes and Alkynes. Elimination Reactions 10. Alkenes and Alkynes. Addition Reactions 11. Free Radical Addition and Substitution Reactions III. Conjugation, Electronic Effects, Carbonyl Groups 12. Conjugated and Aromatic Molecules 13. Carbonyl Compounds. Ketones, Aldehydes, and Carboxylic Acids 14. Substituent Effects 15. Carbonyl Compounds. Esters, Amides, and Related Molecules IV. Carbonyl and Pericyclic Reactions and Mechanisms 16. Carbonyl Compounds. Addition and Substitution Reactions 17. Oxidation and Reduction Reactions 18. Reactions of Enolate Ions and Enols 19. Cyclization and Pericyclic Reactions *(Not yet Posted) V. Bioorganic Compounds 20. Carbohydrates 21. Lipids 22. Peptides, Proteins, and α−Amino Acids 23. Nucleic Acids **************************************************************************************
  • Inosine Binds to A3 Adenosine Receptors and Stimulates Mast Cell Degranulation

    Inosine Binds to A3 Adenosine Receptors and Stimulates Mast Cell Degranulation

    Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. X Jin, … , B R Duling, J Linden J Clin Invest. 1997;100(11):2849-2857. https://doi.org/10.1172/JCI119833. Research Article We investigated the mechanism by which inosine, a metabolite of adenosine that accumulates to > 1 mM levels in ischemic tissues, triggers mast cell degranulation. Inosine was found to do the following: (a) compete for [125I]N6- aminobenzyladenosine binding to recombinant rat A3 adenosine receptors (A3AR) with an IC50 of 25+/-6 microM; (b) not bind to A1 or A2A ARs; (c) bind to newly identified A3ARs in guinea pig lung (IC50 = 15+/-4 microM); (d) lower cyclic AMP in HEK-293 cells expressing rat A3ARs (ED50 = 12+/-5 microM); (e) stimulate RBL-2H3 rat mast-like cell degranulation (ED50 = 2.3+/-0.9 microM); and (f) cause mast cell-dependent constriction of hamster cheek pouch arterioles that is attenuated by A3AR blockade. Inosine differs from adenosine in not activating A2AARs that dilate vascular smooth muscle and inhibit mast cell degranulation. The A3 selectivity of inosine may explain why it elicits a monophasic arteriolar constrictor response distinct from the multiphasic dilator/constrictor response to adenosine. Nucleoside accumulation and an increase in the ratio of inosine to adenosine may provide a physiologic stimulus for mast cell degranulation in ischemic or inflamed tissues. Find the latest version: https://jci.me/119833/pdf Inosine Binds to A3 Adenosine Receptors and Stimulates Mast Cell Degranulation Xiaowei Jin,* Rebecca K. Shepherd,‡ Brian R. Duling,‡ and Joel Linden‡§ *Department of Biochemistry, ‡Department of Molecular Physiology and Biological Physics, and §Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908 Abstract Mast cells are found in the lung where they release media- tors that constrict bronchiolar smooth muscle.
  • Adenosine Challenge Information for Patients Your Doctor Has Recommended That You Have an Adenosine Challenge

    Adenosine Challenge Information for Patients Your Doctor Has Recommended That You Have an Adenosine Challenge

    Adenosine challenge Information for patients Your doctor has recommended that you have an adenosine challenge. The purpose of this test is to see if you have an accessory pathway called ‘Wolff-Parkinson-White (WPW) syndrome’. What is an accessory pathway? This is an extra electrical connection between the top chambers (atria) and bottom chambers (ventricles) of the heart. This extra electrical connection may allow electrical signals to bypass the normal route in your heart and form a short circuit. This can result in your heart beating abnormally fast for periods of time, which is called supra-ventricular tachycardia (SVT). This is not usually dangerous, but can cause unpleasant symptoms, such as a racing heart (palpitations), dizziness, chest pain, shortness of breath or, rarely, may cause you to collapse. Although the extra connection is present from birth (congenital), symptoms may not develop until later in life. In some cases, WPW syndrome may be life-threatening, particularly if it occurs alongside a type of irregular heartbeat called atrial fibrillation. However, this is rare and treatment can completely remove this risk. page 2 How is an accessory pathway diagnosed? Adenosine is the drug used in this test. It belongs to a group of medicines called anti-arrhythmics. Adenosine blocks electrical signals through the atrio-ventricular (AV) node. This means signals cannot travel from the top to the bottom chambers of the heart for a few seconds, until the drug effects wear off. If an accessory pathway (extra connection) is present, the electrical signals can still travel down to the ventricles, and this will show up on the ECG.
  • Gout: a Low-Purine Diet Makes a Difference

    Gout: a Low-Purine Diet Makes a Difference

    Patient HANDOUT Gout: A Low-Purine Diet Makes a Difference Gout occurs when high levels of uric acid in your blood cause crystals to form and build up around a joint. Your body produces uric acid when it breaks down purines. Purines occur naturally in your body, but you also get them from certain foods and drinks. By following a low-purine diet, you can help your body control the production of uric acid and lower your chances of having another gout attack. Purines are found in many healthy foods and drinks. The purpose of a low-purine diet is to lower the amount of purine that you consume each day. Avoid Beer High-Purine Foods Organ meats (e.g., liver, kidneys), bacon, veal, venison Anchovies, sardines, herring, scallops, mackerel Gravy (purines leach out of the meat during cooking so gravy made from drippings has a higher concentration of purines) Limit Moderate- Chicken, beef, pork, duck, crab, lobster, oysters, shrimp : 4-6 oz daily Purine Foods Liquor: Limit alcohol intake. There is evidence that risk of gout attack is directly related to level of alcohol consumption What Other Dietary Changes Can Help? • Choose low-fat or fat-free dairy products. Studies show that low- or non-fat milk and yogurt help reduce the chances of having a gout attack. • Drink plenty of fluids (especially water) which can help remove uric acid from your body. Avoid drinks sweetened with fructose such as soft drinks. • Eat more non-meat proteins such as legumes, nuts, seeds and eggs. • Eat more whole grains and fruits and vegetables and less refined carbohydrates, such as white bread and cakes.
  • Lethality of Adenosine for Cultured Mammalian Cells by Interference with Pyrimidine Biosynthesis

    Lethality of Adenosine for Cultured Mammalian Cells by Interference with Pyrimidine Biosynthesis

    J. Cell Set. 13, 429-439 (i973) 429 Printed in Great Britain LETHALITY OF ADENOSINE FOR CULTURED MAMMALIAN CELLS BY INTERFERENCE WITH PYRIMIDINE BIOSYNTHESIS K. ISHII* AND H. GREEN Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, U.S.A. SUMMARY Adenosine at low concentration is toxic to mammalian cells in culture. This may escape notice because some sera (such as calf or human) commonly used in culture media, contain adenosine deaminase. In the absence of serum deaminase, adenosine produced inhibition of growth of a number of established cell lines at concentrations as low as 5 x io~* M, and killed at 2 x io~5 M. This effect required the presence of cellular adenosine kinase, since a mutant line deficient in this enzyme was 70-fold less sensitive to adenosine. The toxic substance is therefore derived from adenosine by phosphorylation, and is probably one of the adenosine nucleotides. The toxic effect of adenosine in concentrations up to 2 x io~* M was completely prevented by the addition of uridine or of pyrimidines potentially convertible to uridine, suggesting that the adenosine was interfering with endogenous synthesis of uridylate. In the presence of adenosine, the conversion of labelled aspartate to uridine nucleotides was reduced by 80-85 %> and labelled orotate accumulated in both the cells and in the culture medium. The lethality of adenosine results from inhibition by one of its nucleotide products of the synthesis of uridylate at the stage of phosphoribosylation of orotate. INTRODUCTION Though adenosine is not an intermediate on the endogenous pathway of purine biosynthesis, it can be efficiently utilized through the purine salvage pathways as the sole purine source in cultured mammalian cells whose endogenous purine synthesis is blocked by aminopterin (Green & Ishii, 1972).
  • Inosine in Biology and Disease

    Inosine in Biology and Disease

    G C A T T A C G G C A T genes Review Inosine in Biology and Disease Sundaramoorthy Srinivasan 1, Adrian Gabriel Torres 1 and Lluís Ribas de Pouplana 1,2,* 1 Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, 08028 Barcelona, Catalonia, Spain; [email protected] (S.S.); [email protected] (A.G.T.) 2 Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Catalonia, Spain * Correspondence: [email protected]; Tel.: +34-934034868; Fax: +34-934034870 Abstract: The nucleoside inosine plays an important role in purine biosynthesis, gene translation, and modulation of the fate of RNAs. The editing of adenosine to inosine is a widespread post- transcriptional modification in transfer RNAs (tRNAs) and messenger RNAs (mRNAs). At the wobble position of tRNA anticodons, inosine profoundly modifies codon recognition, while in mRNA, inosines can modify the sequence of the translated polypeptide or modulate the stability, localization, and splicing of transcripts. Inosine is also found in non-coding and exogenous RNAs, where it plays key structural and functional roles. In addition, molecular inosine is an important secondary metabolite in purine metabolism that also acts as a molecular messenger in cell signaling pathways. Here, we review the functional roles of inosine in biology and their connections to human health. Keywords: inosine; deamination; adenosine deaminase acting on RNAs; RNA modification; translation Citation: Srinivasan, S.; Torres, A.G.; Ribas de Pouplana, L. Inosine in 1. Introduction Biology and Disease. Genes 2021, 12, 600. https://doi.org/10.3390/ Inosine was one of the first nucleobase modifications discovered in nucleic acids, genes12040600 having been identified in 1965 as a component of the first sequenced transfer RNA (tRNA), tRNAAla [1].
  • Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells

    Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells

    Effects of allopurinol and oxipurinol on purine synthesis in cultured human cells William N. Kelley, James B. Wyngaarden J Clin Invest. 1970;49(3):602-609. https://doi.org/10.1172/JCI106271. Research Article In the present study we have examined the effects of allopurinol and oxipurinol on thed e novo synthesis of purines in cultured human fibroblasts. Allopurinol inhibits de novo purine synthesis in the absence of xanthine oxidase. Inhibition at lower concentrations of the drug requires the presence of hypoxanthine-guanine phosphoribosyltransferase as it does in vivo. Although this suggests that the inhibitory effect of allopurinol at least at the lower concentrations tested is a consequence of its conversion to the ribonucleotide form in human cells, the nucleotide derivative could not be demonstrated. Several possible indirect consequences of such a conversion were also sought. There was no evidence that allopurinol was further utilized in the synthesis of nucleic acids in these cultured human cells and no effect of either allopurinol or oxipurinol on the long-term survival of human cells in vitro could be demonstrated. At higher concentrations, both allopurinol and oxipurinol inhibit the early steps ofd e novo purine synthesis in the absence of either xanthine oxidase or hypoxanthine-guanine phosphoribosyltransferase. This indicates that at higher drug concentrations, inhibition is occurring by some mechanism other than those previously postulated. Find the latest version: https://jci.me/106271/pdf Effects of Allopurinol and Oxipurinol on Purine Synthesis in Cultured Human Cells WILLIAM N. KELLEY and JAMES B. WYNGAARDEN From the Division of Metabolic and Genetic Diseases, Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27706 A B S TR A C T In the present study we have examined the de novo synthesis of purines in many patients.
  • The Interaction of Selective A1 and A2A Adenosine Receptor Antagonists with Magnesium and Zinc Ions in Mice: Behavioural, Biochemical and Molecular Studies

    The Interaction of Selective A1 and A2A Adenosine Receptor Antagonists with Magnesium and Zinc Ions in Mice: Behavioural, Biochemical and Molecular Studies

    International Journal of Molecular Sciences Article The Interaction of Selective A1 and A2A Adenosine Receptor Antagonists with Magnesium and Zinc Ions in Mice: Behavioural, Biochemical and Molecular Studies Aleksandra Szopa 1,* , Karolina Bogatko 1, Mariola Herbet 2 , Anna Serefko 1 , Marta Ostrowska 2 , Sylwia Wo´sko 1, Katarzyna Swi´ ˛ader 3, Bernadeta Szewczyk 4, Aleksandra Wla´z 5, Piotr Skałecki 6, Andrzej Wróbel 7 , Sławomir Mandziuk 8, Aleksandra Pochodyła 3, Anna Kudela 2, Jarosław Dudka 2, Maria Radziwo ´n-Zaleska 9, Piotr Wla´z 10 and Ewa Poleszak 1,* 1 Chair and Department of Applied and Social Pharmacy, Laboratory of Preclinical Testing, Medical University of Lublin, 1 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (K.B.); [email protected] (A.S.); [email protected] (S.W.) 2 Chair and Department of Toxicology, Medical University of Lublin, 8 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (M.H.); [email protected] (M.O.); [email protected] (A.K.) [email protected] (J.D.) 3 Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, 1 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (K.S.);´ [email protected] (A.P.) 4 Department of Neurobiology, Polish Academy of Sciences, Maj Institute of Pharmacology, 12 Sm˛etnaStreet, PL 31–343 Kraków, Poland; [email protected] 5 Department of Pathophysiology, Medical University of Lublin, 8 Jaczewskiego Street, PL 20–090 Lublin, Poland; [email protected] Citation: Szopa, A.; Bogatko, K.; 6 Department of Commodity Science and Processing of Raw Animal Materials, University of Life Sciences, Herbet, M.; Serefko, A.; Ostrowska, 13 Akademicka Street, PL 20–950 Lublin, Poland; [email protected] M.; Wo´sko,S.; Swi´ ˛ader, K.; Szewczyk, 7 Second Department of Gynecology, 8 Jaczewskiego Street, PL 20–090 Lublin, Poland; B.; Wla´z,A.; Skałecki, P.; et al.
  • Purine Metabolism in the Protozoan Parasite Eimeria Tenella (Hypoxanthine-Xanthine-Guanine Phosphoribosyltransferase/GMP-Agarose Affinity Column/Alopurinol) C

    Purine Metabolism in the Protozoan Parasite Eimeria Tenella (Hypoxanthine-Xanthine-Guanine Phosphoribosyltransferase/GMP-Agarose Affinity Column/Alopurinol) C

    Proc. NatL Acad. Sci. USA Vol. 78, No. 11, pp. 6618-6622, November 1981 Biochemistry Purine metabolism in the protozoan parasite Eimeria tenella (hypoxanthine-xanthine-guanine phosphoribosyltransferase/GMP-agarose affinity column/alopurinol) C. C. WANG AND P. M. SIMASHKEVICH* Merck Institute for Therapeutic Research, Rahway, New Jersey 07065 Communicated by P. Roy Vagelos, June 25, 1981 ABSTRACT Crude extracts of the oocysts ofEimeria tenella, cidia Eimenria tenella, which develops inside the caecal epithe- a protozoan parasite of the coccidium family that develops inside lial cells ofchickens, effectively takes up hypoxanthine and pref- the caecal epithelial cells ofinfected chickens, do not incorporate erentially incorporates label from it into nucleic acids when glycine or formate into purine nucleotides; this suggests lack of grown in cell culture (13, 14). Purine metabolism in this parasite capability for de novo purine synthesis by the parasite. The ex- is particularly interesting in view of the uricotelic metabolism tracts, however, contain high levels of activity of the purine sal- of chickens and the high levels of hypoxanthine known to ac- vage enzymes: hypoxanthine, guanine, xanthine, and adenine cumulate in avian tissues phosphoribosyltransferases and adenosine kinase. The absence of (15). AMP deaminase from the parasite indicates thatE. tenella cannot In this study, we have demonstrated that E. tenella cannot convert AMP to GMP; the latter thus has to be supplied by the perform de novo purine synthesis and examined the detailed hypoxanthine, xanthine, or guanine phosphoribosyltransferase of mechanism of purine salvage. A purine phosphoribosyltrans- the parasite. These three activities are associatedwith one enzyme ferase that uses hypoxanthine and guanine as well as xanthine (HXGPRTase), which has been purified to near homogeneity in as substrates (HXGPRTase) was identified in the parasite.
  • Adenosine A1 Receptor-Mediated Activation of Phospholipase C in Cultured Astrocytes Depends on the Level of Receptor Expression

    Adenosine A1 Receptor-Mediated Activation of Phospholipase C in Cultured Astrocytes Depends on the Level of Receptor Expression

    The Journal of Neuroscience, July 1, 1997, 17(13):4956–4964 Adenosine A1 Receptor-Mediated Activation of Phospholipase C in Cultured Astrocytes Depends on the Level of Receptor Expression Knut Biber,1,2 Karl-Norbert Klotz,3 Mathias Berger,1 Peter J. Gebicke-Ha¨ rter,1 and Dietrich van Calker1 1Department of Psychiatry, University of Freiburg, D-79104 Freiburg, Germany, 2Institute for Biology II, University of Freiburg, D-79104 Freiburg, Germany, and 3Institute for Pharmacology and Toxicology, University of Wu¨ rzburg, D-97078 Wu¨ rzburg, Germany Adenosine A1 receptors induce an inhibition of adenylyl cyclase dependent on the expression level of A1 receptor, and (4) the via G-proteins of the Gi/o family. In addition, simultaneous potentiating effect on PLC activity is unrelated to extracellular stimulation of A1 receptors and of receptor-mediated activation glutamate. of phospholipase C (PLC) results in a synergistic potentiation of Taken together, our data support the notion that bg subunits PLC activity. Evidence has accumulated that Gbg subunits are the relevant signal transducers for A1 receptor-mediated mediate this potentiating effect. However, an A1 receptor- PLC activation in rat astrocytes. Because of the lower affinity of mediated increase in extracellular glutamate was suggested to bg, as compared with a subunits, more bg subunits are re- be responsible for the potentiating effect in mouse astrocyte quired for PLC activation. Therefore, only in cultures with higher cultures. We have investigated the synergistic activation of PLC levels of adenosine A1 receptors is the release of bg subunits by adenosine A1 and a1 adrenergic receptors in primary cul- via Gi/o activation sufficient to stimulate PLC.
  • The Effects of Adenosine Antagonists on Distinct Aspects of Motivated Behavior: Interaction with Ethanol and Dopamine Depletion

    The Effects of Adenosine Antagonists on Distinct Aspects of Motivated Behavior: Interaction with Ethanol and Dopamine Depletion

    Facultat de Ciències de la Salut Departament de Psicologia Bàsica, Clínica i Psicobiologia The effects of adenosine antagonists on distinct aspects of motivated behavior: interaction with ethanol and dopamine depletion. PhD Candidate Laura López Cruz Advisor Dr. Mercè Correa Sanz Co-advisor Dr. John D.Salamone Castelló, May 2016 Als meus pares i germà A Carlos AKNOWLEDGEMENTS This work was funded by two competitive grants awarded to Mercè Correa and John D. Salamone: Chapters 1-4: The experiments in the first chapters were supported by Plan Nacional de Drogas. Ministerio de Sanidad y Consumo. Spain. Project: “Impacto de la dosis de cafeína en las bebidas energéticas sobre las conductas implicadas en el abuso y la adicción al alcohol: interacción de los sistemas de neuromodulación adenosinérgicos y dopaminérgicos”. (2010I024). Chapters 5 and 6: The last 2 chapters contain experiments financed by Fundació Bancaixa-Universitat Jaume I. Spain. Project: “Efecto del ejercicio físico y el consumo de xantinas sobre la realización del esfuerzo en las conductas motivadas: Modulación del sistema mesolímbico dopaminérgico y su regulación por adenosina”. (P1.1B2010-43). Laura López Cruz was awarded a 4-year predoctoral scholarship “Fornación de Profesorado Universitario-FPU” (AP2010-3793) from the Spanish Ministry of Education, Culture and Sport. (2012/2016). TABLE OF CONTENTS ABSTRACT ...................................................................................................................1 RESUMEN .....................................................................................................................3